Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis
Journal of Internal Medicine · 2025
DOI: 10.1111/joim.70025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, 2025. Verfasst von Rakel Nurmi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Celiac Disease Research Center, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Celiac Disease, Transglutaminases, Autoantibodies, GTP-Binding Proteins. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Due to the expanding screening of coeliac disease (CeD), low positive and borderline negative serum transglutaminase 2 antibody (TGA) values are causing increasing confusion in clinical practice.
Objectives
To investigate the significance of these findings in a well‐defined patient cohort.
Methods
Altogether 311 IgA‐competent adults, with clinical suspicion or family history of CeD, underwent duodenal sampling and testing for TGA (ImmunoCAP EliA, cut‐off 7.0 U/mL) and endomysial antibodies (EmA). TGA values 7.0–14.0 U/mL were defined as low positive and 3.0–6.9 U/mL as borderline negative. Besides conventional histology, small bowel mucosal TGA‐targeted IgA deposits and γδ+ intraepithelial lymphocytes (IELs) were determined as CeD‐specific markers.
Results
Twenty‐eight (9%) individuals had low positive TGA, and 22 (79%) were also positive for EmA. Among those with low positive TGA, all EmA positive and 50% of the EmA negative subjects were diagnosed with CeD. Thirty‐nine individuals (13%) had borderline negative TGA, and 36% were positive for EmA. Of these, 79% of EmA positive and 12% of EmA negative subjects were diagnosed with CeD. Additionally, 29% of the subjects with borderline negative TGA and no diagnosis exhibited signs of incipient CeD, including positive IgA deposits, increased density of γδ+ IELs and presence of human leukocyte antigen DQ2/DQ8. All subjects with TGA ≥ 3.2× upper limit of normal (22.4 U/mL) received a CeD diagnosis.
Conclusion
Low positive and borderline negative TGA frequently implies a CeD diagnosis, particularly in EmA positive individuals, or at least may be an indicator of an early stage of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Celiac Disease Research Center, Tampere University, Tampere, Finland.
- Department of Internal Medicine, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
- Tampere Center for Child, Adolescent, and Maternal Health Research, Tampere University, Tampere, Finland.
- Department of Pediatrics, Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
- University Consortium of Seinäjoki, Seinäjoki, Finland.
- Faculty of Social Sciences, University of Tampere, Tampere, Finland.
ORCID-Profile: Kalle Kurppa, Heini Huhtala, Saana Paavola
Zitieren
APA
Nurmi, R., Turunen Beteta, C., Kurppa, K., Huhtala, H., Lindfors, K., Kivelä, L., Kaukinen, K., & Paavola, S. (2025). Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis. Journal of Internal Medicine. https://doi.org/10.1111/joim.70025
Vancouver
Nurmi R, Turunen Beteta C, Kurppa K, Huhtala H, Lindfors K, Kivelä L, et al. Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis. Journal of Internal Medicine. 2025. doi:10.1111/joim.70025
BibTeX
@article{Nurmi2025,
author = {Nurmi, Rakel and Turunen Beteta, Celina and Kurppa, Kalle and Huhtala, Heini and Lindfors, Katri and Kivelä, Laura and Kaukinen, Katri and Paavola, Saana},
title = {Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis},
journal = {Journal of Internal Medicine},
year = {2025},
doi = {10.1111/joim.70025}
}
EUVIMED